Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,784 shares at $499.00 ($1.9M) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Scheduled sale ($1.9M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |
| VRTX | SELL | 2024-02-14 | $2.8M | — | Filing → |